Navigation Links
ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
Date:6/17/2010

CONSHOHOCKEN, Pa., June 17 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical research technologies and niche clinical services, launches version 3.0 of its eMVR (Electronic Monitor Visit Report) application with new features to support online and offline completion of monitoring reports for traveling clinical research associates and integrations with leading CTMS systems.

"Our latest release provides study monitors with the option of completing monitor reports online or offline, more robust reporting, and CTMS integration points," stated Steven Beales, ePharmaSolutions' Vice President of Information Technology.

ePharmaSolutions' Clinical Trial Portal (CTP) is used by more than 200,000 clinical researchers in 107 countries to help accelerate and improve site feasibility, study training, site activation and patient enrollment.  CTP version 4.0 contains new functionality for sponsors that includes eMVR (Electronic Monitor Visit Report) to support the authoring, completion and submission of online and offline monitor trip reports with electronic signature.  The new version of eMVR allows study monitors to complete their site visit reports online or offline in Microsoft Word.  The offline reports can be submitted back to the eMVR and the data is pulled from the Word template back into the system.  The eMVR auto-populates visit reports, confirmation and follow-up letters, and carries all follow-up data from one report to either follow-up letters or future visit reports.  The eMVR includes a robust tracking and reporting system for study managers and integrates with leading CTMS systems.

"Our clients have been asking for an offline monitor visit report completion feature for some time and the market has not been responding in a timely enough manner," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Our development team did an excellent job building out these features into this release to support the global needs of our biopharmaceutical and CRO clients," Converse added.

ePharmaSolutions' Clinical Trial Portal (CTP) provides biopharmaceutical companies and CROs with a fully validated solution to help accelerate and improve study start-up and site management through a variety of "Site Friendly" components that include: site feasibility application (SFA), secure document exchange (SDE), safety letter distribution (SLD), electronic monitor visit reporting (eMVR), learning management system (LMS), and the patient recruitment manager (PRM).  Future plans in 2010 include the inclusion of a grant payment tracking application for sponsors/sites and integration of 80 million EMR records into its investigator database for improved decision support during the site selection process.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to start clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world and is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
8. Premier Micronutrient Launches Supplement for Hearing Health
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):